Moolec Science (MLEC)
NASDAQ:MLEC
MLEC Stock Chart & Stats
$4.11
-$0.04(-4.25%)
At close: 4:00 PM EST
$4.11
-$0.04(-4.25%)
Day’s Range― - ―
52-Week Range$3.08 - $157.06
Previous CloseN/A
Volume11.69K
Average Volume (3M)209.37K
Market Cap
$5.24M
Enterprise Value$25.40M
Total Cash (Recent Filing)$1.93M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.47
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,118
10 Day Avg. Volume506,476
30 Day Avg. Volume209,369
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.12
P/FCF Ratio-1.35
Enterprise Value/Market Cap4.84
Enterprise Value/Revenue3.24
Enterprise Value/Gross Profit-39.72
Enterprise Value/Ebitda-4.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sharp Revenue Ramp & Improving Gross MarginA large FY2025 revenue ramp combined with a jump in gross margin to ~34% shows the company is converting R&D into commercial sales and improving unit economics. This structural revenue and margin improvement supports a sustainable path to scale and eventual operating leverage if cost growth moderates.
Proprietary Molecular Farming PlatformMoolec's plant-based molecular farming is a differentiated, capital-light route to produce specialty proteins and bioactives at scale. The seed-to-ingredient approach can lower production costs versus fermentation, create high barriers to entry, and enable product diversification across food and nutraceutical markets over the medium term.
Board Refresh Adds Quality And Operations ExpertiseAdding an experienced quality/operations director strengthens governance and industrialization capabilities. That enhances compliance, manufacturing discipline and regulatory readiness—durable improvements that reduce execution risk as the company scales ingredient production across multiple regions.
Bears Say
Negative Equity And High DebtNegative equity combined with materially higher debt weakens the balance sheet and limits financial flexibility. This elevated leverage raises refinancing and covenant risk, making the company more vulnerable to funding shocks and constraining strategic options over the coming months.
Ongoing Cash Burn And Negative Free Cash FlowSustained operating and free cash outflows imply continued dependency on external funding. Persistent cash burn pressures near-term liquidity and could force dilutive financing or operational cutbacks, challenging the company’s ability to execute commercialization plans without raising new capital.
Listing Compliance Reliant On One-time Accounting GainsRelying on derecognition gains tied to subsidiary bankruptcies to meet Nasdaq equity standards is a structural risk. These are one-off accounting events, not operational earnings, leaving listing status and investor confidence contingent on complex legal/accounting outcomes and not on core business performance.
Moolec Science News
MLEC FAQ
What was Moolec Science’s price range in the past 12 months?
Moolec Science lowest stock price was $3.08 and its highest was $157.06 in the past 12 months.
What is Moolec Science’s market cap?
Moolec Science’s market cap is $5.24M.
When is Moolec Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Moolec Science’s earnings last quarter?
Currently, no data Available
Is Moolec Science overvalued?
According to Wall Street analysts Moolec Science’s price is currently Overvalued.
Does Moolec Science pay dividends?
Moolec Science does not currently pay dividends.
What is Moolec Science’s EPS estimate?
Moolec Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Moolec Science have?
Moolec Science has 726,118 shares outstanding.
What happened to Moolec Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Moolec Science?
Currently, no hedge funds are holding shares in MLEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Moolec Science
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Technical Analysis
AIM ImmunoTech
―
Ensysce Biosciences
―
Cyclerion Therapeutics
―
―
Calidi Biotherapeutics
―